Obesity drugs
Zealand Pharma’s stock swings show weight-loss drug market’s new test
Survodutide’s dropout rates cooled enthusiasm, but investors are watching whether amylin-based petrelintide can offer a more tolerable obesity treatment
Biotech stocks news
Read verified news on BetaVoices covering Biotech stocks, with reporting, context, and related developments.
#Biotech stocks
Clear filters